Identification of prognostic and therapeutic biomarkers in type 2 papillary renal cell carcinoma

Identification of prognostic and therapeutic biomarkers in type 2 papillary renal cell carcinoma

Abstract Background Papillary renal cell carcinoma (PRCC) can be divided into type 1 (PRCC1) and type 2 (PRCC2) and PRCC2 share a more invasive phenotype and worse prognosis. This study aims to identify potential prognostic and therapeutic biomarkers in PRCC2. Methods A cohort from The Cancer Genome...

Full description

Bibliographic Details
Main Authors: Yue Wang, Xi Tian, Shu-Xuan Zhu, Wen-Hao Xu, Aihetaimujiang Anwaier, Jia-Qi Su, Hua-Lei Gan, Yuan-Yuan Qu, Jian-Yuan Zhao, Hai-Liang Zhang, Ding-Wei Ye
Format: Article
Language:English
Published: BMC 2023-03-01
Series:World Journal of Surgical Oncology
Subjects:
Type 2 papillary renal cell carcinoma
Prognosis
mTOR inhibitor
Biomarker
Online Access:https://doi.org/10.1186/s12957-022-02836-3

Internet

https://doi.org/10.1186/s12957-022-02836-3

Similar Items